LPL Financial
CTSO icon

LPL Financial’s Cytosorbents Corp CTSO Stock Holding History

LPL Financial’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.1K Buy
23,185
+119
+0.5% +$81 ﹤0.01% 5902
2025
Q4 		$14.7K Buy
23,066
+8,160
+55% +$6.28K ﹤0.01% 5831
2025
Q3 		$13.9K Buy
+14,906
New +$14.7K ﹤0.01% 5759

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

LPL Financial's CTSO Position: Q1 2026 in Review

LPL Financial increased its Cytosorbents Corp (CTSO) stake by 0.52% in Q1 2026, buying an estimated $81 and bringing the position to 23,185 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5902.

LPL Financial first reported a position in CTSO in Q3 2025 and has held it in 3 quarters since. The position peaked at $14.7K in Q4 2025. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • LPL Financial held 23,185 shares of Cytosorbents Corp worth $13.1K as of Q1 2026.
  • LPL Financial bought 119 Cytosorbents Corp shares in Q1 2026, an estimated $81.
  • Cytosorbents Corp made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5902 holding.
  • LPL Financial first reported a position in Cytosorbents Corp in Q3 2025 and has held it in 3 quarters since.
  • LPL Financial's Cytosorbents Corp position peaked at $14.7K in Q4 2025.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.